2022-02-10T11:27:12-06:00 2021-06-30 363963131 MANN WEITZ & ASSOCIATES LLC 111 DEER LAKE ROAD SUITE 125 DEERFIELD IL 60015 990 2020-07-01 366102182 LEUKEMIA RESEARCH FOUNDATION LEUK 8474240600 191 WAUKEGAN ROAD NO 105 NORTHFIELD IL 60093 KEVIN RADELET EXECUTIVE DIRECTOR 8474240600 2022-02-10 1 KEVIN RADELET 999009999 MARCY STEINDLER P00573131 8472673400 2 AAL1 IAL1 2020 2022-09-23 18:48:47Z KEVIN RADELET 191 WAUKEGAN ROAD NO 105 NORTHFIELD IL 60093 2592779 0 X WWW.ALLBLOODCANCERS.ORG X 1951 IL THE LEUKEMIA RESEARCH FOUNDATION IS DEDICATED TO CONQUERING ALL BLOOD CANCERS BY FUNDING RESEARCH INTO THEIR CAUSES AND CURES, AND ENRICHING THE QUALITY OF LIFE OF THOSE TOUCHED BY THESE DISEASES. 14 14 7 250 0 0 2598095 2574542 0 0 22499 -16225 0 3755 2620594 2562072 1453801 1550597 0 0 746934 717325 0 0 245812 259747 204274 2460482 2472196 160112 89876 4154136 4522929 1385627 1448622 2768509 3074307 DEDICATED TO CONQUERING ALL BLOOD CANCERS BY FUNDING RESEARCH INTO ITS CAUSES AND CURES AND ENRICHING THE QUALITY OF LIFE OF THOSE TOUCHED BY THESE DISEASES. 0 0 1477914 1400000 WE FUND PROMISING RESEARCH WORLDWIDE TO ACCELERATE THE DEVELOPMENT OF NEW TREATMENTS AND THERAPIES FOR ALL BLOOD CANCERS, INCLUDING LEUKEMIA, LYMPHOMA, MYELOMA, AND MYELODYSPLASTIC SYNDROMES. OUR RESEARCHERS' PROJECTS IN GENOMICS, IMMUNOTHERAPIES, AND STEM CELL BIOLOGY HAVE ADVANCED OUR UNDERSTANDING OF WHAT DRIVES THESE CANCERS TO FORM AND PROGRESS AND WHAT BIOLOGICAL MARKERS COULD BE TARGETS FOR TREATMENT. IN FISCAL YEAR 2021, WE AWARDED FOURTEEN $100,000 GRANTS TO RESEARCHERS WORLDWIDE. 225236 150597 OUR NEED-BASED PATIENT GRANT PROGRAM IS INTENDED TO ASSIST PATIENTS AND THEIR FAMILIES BY EASING THE FINANCIAL BURDEN SO THEY CAN FOCUS ON THEIR HEALTH AND TREATMENT. ELIGIBLE PATIENTS WITH LEUKEMIA, LYMPHOMA, MYELOMA, OR MYELODYSPLASTIC SYNDROME CAN RECEIVE A ONE-TIME GRANT OF UP TO $1,500. IN FISCAL YEAR 2021, WE DISPERSED GRANTS TO 100 PATIENTS. 297525 THROUGH OUR FREE EDUCATION CONFERENCES AND WEBINARS, PATIENTS AND THEIR LOVED ONES CAN LEARN ABOUT VARIOUS BLOOD CANCER-RELATED TOPICS AND SPEAK WITH EXPERT HEMATOLOGY/ONCOLOGY PHYSICIANS. IN FISCAL YEAR 2021, APPROXIMATELY 836 PEOPLE REGISTERED FOR OUR EDUCATION PROGRAMS.WE ALSO OFFER FREE PEER SUPPORT SERVICES TO BLOOD CANCER PATIENTS AND CAREGIVERS, INCLUDING AN ONLINE SUPPORT COMMUNITY, AND PARTNER WITH A CANCER SUPPORT ORGANIZATION TO PROVIDE A PEER MENTORING PROGRAM. IN FISCAL YEAR 2021, MORE THAN 4,000 PEOPLE PARTICIPATED IN OUR PEER SUPPORT PROGRAMS. 2000675 1 1 0 0 0 0 0 0 0 1 1 0 0 1 0 1 1 0 0 0 1 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 3 0 1 7 1 0 0 0 0 0 0 0 0 0 0 0 0 X 14 14 1 0 0 0 0 0 0 1 1 0 1 1 1 1 1 1 1 1 1 0 0 AK CA CT FL GA IL ME MD MA MI MO MT NJ NC NY OH OK TX TN RI OR UT VA WA WV WI X X ARLEEN BOUDART 8474240600 191 WAUKEGAN ROAD SUITE 105 NORTHFIELD IL 60093 BLAKE BRANDWEIN PRESIDENT 0.50 X X 0 0 0 GERALD BRIN TREASURER 0.50 X X 0 0 0 PATTY MIX SECRETARY 0.50 X X 0 0 0 ROBERT GRABEMANN GENERAL COUNSEL 0.50 X 0 0 0 HARVEY BRIN AT LARGE MEMBER 0.50 X 0 0 0 MARCIA BRIN AT LARGE MEMBER 0.50 X 0 0 0 JOHN BURKE AT LARGE MEMBER 0.50 X 0 0 0 TODD HOLMES AT LARGE MEMBER 0.50 X 0 0 0 FRANK MARTINEZ AT LARGE MEMBER 0.50 X 0 0 0 LARRY MIX AT LARGE MEMBER 0.50 X 0 0 0 RANDI SCHULLO AT LARGE MEMBER 0.50 X 0 0 0 STEVE WILENSKY AT LARGE MEMBER 0.50 X 0 0 0 GREGG ROSSIER AT LARGE MEMBER 0.50 X 0 0 0 RONG CHEN AT LARGE MEMBER 0.50 X 0 0 0 KEVIN RADELET EXECUTIVE DIRECTOR 37.50 X 130289 0 11659 130289 0 11659 1 0 0 0 0 29225 186901 2358416 2574542 14482 14482 30707 -30707 -30707 -30707 OTHER INCOME 900099 3755 3755 3755 2562072 0 0 -12470 1300000 1300000 150597 150597 100000 100000 146394 72723 35286 38385 468753 232857 112987 122909 55712 27675 13429 14608 46466 23082 11200 12184 20600 20600 5681 1704 3977 31390 16486 12019 2885 25177 13344 5791 6042 64112 39109 12181 12822 8447 8377 34 36 1301 690 299 312 6474 3949 1230 1295 FUNDRAISING CAMPAIGNS 36317 8579 27738 MISCELLANEOUS 4154 1174 510 2470 DUES AND SUBSCRIPTIONS 621 329 143 149 2472196 2000675 225709 245812 904892 511666 109879 423765 125329 556556 18698 9225 134506 132788 3020 1718 2519971 2532316 472347 487683 4154136 4522929 29896 24341 1266631 1424281 89100 1385627 1448622 X 2216231 2505927 552278 568380 2768509 3074307 4154136 4522929 X 89876 30696 185227 X 0 1 X 1 0 X 2265402 2554974 2378441 2598095 2574542 12371454 2265402 2554974 2378441 2598095 2574542 12371454 542240 11829214 50 30 7957 22499 14471 45007 2133 237 3755 6125 12422586 0.95220 0.93830 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 84594 1220 454 85360 83945 1338 689 84594 80000 4636 691 83945 80000 482 482 80000 80000 320 320 80000 1.00000 0 0 97696 96303 1393 36810 36485 325 1718 SECURITY DEPOSIT 4663 BENEFICIAL INTEREST IN TRUST 465732 ANNUITIES RECEIVABLE 17288 487683 X 2777995 108819 107104 215923 2562072 0 2562072 2472197 0 2472197 0 2472197 PART V, LINE 4: THE EARNINGS OF THE FUND ARE TO BE USED TO PROVIDE ASSISTANCE TO PATIENTS AND THEIR FAMILIES AND TO FUND MEDICAL RESEARCH. PART X, LINE 2: THE FINANCIAL STATEMENT EFFECTS OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN ARE RECOGNIZED IN THE FINANCIAL STATEMENTS WHEN IT IS MORE LIKELY THAN NOT, BASED ON THE TECHNICAL MERITS, THAT THE POSITION WILL BE SUSTAINED UPON EXAMINATION. AS OF JUNE 30, 2021, THE FOUNDATION HAD NO UNCERTAIN TAX POSITIONS THAT QUALIFY FOR RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS. PART XI, LINE 2D - OTHER ADJUSTMENTS: CANCELLATION OF GRANTS 107,104. 1 EUROPE 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 100000 0 0 0 0 0 0 100000 0 100000 EUROPE NEW INVESTIGATOR RESEARCH GRANT 100000 WIRE TRANSFER 1 0 0 0 0 0 0 0 PART I, LINE 2: THE FINAL SCIENTIFIC REPORT SHOULD BE RECEIVED WITHIN 30 DAYS OF COMPLETION OF THE PROJECT. GRANTEES ARE RQUIRED TO COMPLETE THE FINAL SCIENTIFIC REPORT FORM AND E-MAIL THE FOUNDATION WITH A BRIEF SCIENTIFIC SUMMARY, A BRIEF LAY SUMMARY, AND A LIST OF ANY RESULTING PUBLICATIONS. PART III ACCOUNTING METHOD: 1 UNIVERSITY OF CALIFORNIA SAN DIEGO 9500 GILMAN DRIVE LA JOLLA CA 92093 956006144 SECTION 115 200000 NEW INVESTIGATOR RESEARCH GRANT UNIVERSITY OF CALIFORNIA SAN FRANCISCO 490 ILLINOIS STREET 4TH FLOOR SAN FRANCISCO CA 94143 946036493 SECTION 115 100000 NEW INVESTIGATOR RESEARCH GRANT THE OHIO STATE UNIVERSITY 1960 KENNY ROAD COLUMBUS OH 43210 316025986 SECTION 115 100000 NEW INVESTIGATOR RESEARCH GRANT DANA-FARBER CANCER INSTITUTE 450 BROOKLINE AVE BOSTON MA 02215 042263040 501(C)(3) 100000 NEW INVESTIGATOR RESEARCH GRANT JOHNS HOPKINS UNIVERSITY 1101 E 33RD STREET B001 BALTIMORE MD 21218 520595110 501(C)(3) 100000 NEW INVESTIGATOR RESEARCH GRANT WASHINGTON UNIVERSITY 660 EUCLID AVE ST LOUIS MO 63110 430653611 501(C)(3) 100000 NEW INVESTIGATOR RESEARCH GRANT UNIVERSITY OF PENNSYLVANIA 3400 CIVIC CENTER BLVD PHILADELPHIA PA 19104 231352685 501(C)(3) 100000 NEW INVESTIGATOR RESEARCH GRANT THE PENNSYLVANIA STATE UNIVERSITY 500 UNIVERSITY DRIVE PO BOX 850 HERSHEY PA 17033 246000376 SECTION 115 100000 NEW INVESTIGATOR RESEARCH GRANT RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER 333 COTTMAN AVE PHILADELPHIA PA 19111 236296135 501(C)(3) 100000 NEW INVESTIGATOR RESEARCH GRANT MAYO CLINIC 200 1ST ST SW ROCHESTER MN 55905 416011702 501(C)(3) 200000 NEW INVESTIGATOR RESEARCH GRANT RUTGERS THE STATE UNIVERSITY OF NEW JERSEY 679 HOES LANE WEST PISCATAWAY NJ 08854 462354111 501(C)(3) 100000 NEW INVESTIGATOR RESEARCH GRANT 11 0 MEDICAL FINANCIAL ASSISTANCE 100 150597 PART I, LINE 2: THE FINAL SCIENTIFIC REPORT SHOULD BE RECEIVED WITHIN 30 DAYS OF COMPLETION OF THE PROJECT. GRANTEES ARE REQUIRED TO COMPLETE THE FINAL SCIENTIFIC REPORT FORM AND E-MAIL THE FOUNDATION WITH A BRIEF SCIENTIFIC SUMMARY, A BRIEF LAY SUMMARY, AND A LIST OF ANY RESULTING PUBLICATIONS. FORM 990, PART VI, SECTION A, LINE 2 HARVEY, MARCIA, AND GERALD BRIN HAVE FAMILY RELATIONSHIPS AND ARE ALSO BOARD MEMBERS. LARRY AND PATTY MIX HAVE FAMILY RELATIONSHIPS AND ARE ALSO BOARD MEMBERS. FORM 990, PART VI, SECTION B, LINE 11B THE FINANCE DIRECTOR AND EXECUTIVE DIRECTOR REVIEW FORM 990. THE FINAL DRAFT OF FORM 990 IS MADE AVAILABLE TO ALL BOARD MEMBERS PRIOR TO FILING. MEMBERS ARE NOTIFIED THAT FORM 990 HAS BEEN POSTED AND THEY CAN ACCESS A URL AND PUT IN THEIR PASSWORD TO VIEW THE DOCUMENT. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY IS REVIEWED ANNUALLY AND MONITORED AS POTENTIAL REFERENCE AND/OR ACTION IS CALLED FOR. FORM 990, PART VI, SECTION B, LINE 15A THE EXECUTIVE DIRECTOR'S SALARY IS DETERMINED BY A COMPENSATION SURVEY. WE USE A WRITTEN EMPLOYMENT CONTRACT THAT IS APPROVED BY THE BOARD FORM 990, PART VI, SECTION C, LINE 19 WE MAKE OUR GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE UPON REQUEST. THE FINANCIAL STATEMENTS ARE AVAILABLE ONLINE AND UPON REQUEST. FORM 990, PART XI, LINE 9: CHANGE IN VALUE OF BENEFICIAL INTEREST IN TRUST 78,123. CANCELLATION OF GRANTS 107,104.